ARCHIVES

Drug Shortages Prompt Doctors, Societies to Consider Non-Profit Pharma Company

This article is from The Cancer Letter archive.

Vol. 37 No. 33 | September 9, 2011

Download PDF Visit The Full Archive

Related Articles

Bennett, CCIRC Members Disagree On state Of Groups, Simons New Chairman

June 27, 1980

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

March 21, 2003

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

Cancer Act Renewal Nears Vote By House

August 11, 1978

Artificial Neural Networks Predict Clinical Outcomes

November 26, 2004